Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

OP93 Anti-BRCA1 (Ab-2) Mouse mAb (MS13)

Anti-BRCA1 (Ab-2), mouse monoclonal, clone MS13, recognizes ~220 kDa BRCA1 in MCF-7 cells. It is validated for Western blotting, immunofluorescence, immunoprecipitation, and for paraffin sections.

Anti-BRCA1 (Ab-2) Mouse mAb (MS13) : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: Anti-Breast Cancer Susceptibility Protein

OP93
Purchase on Sigma-Aldrich

Aperçu

Replacement Information

Tableau de caractéristiques principal

Species ReactivityHostAntibody Type
HMMonoclonal Antibody

Products

RéférenceConditionnement Qté
OP93-100UG Ampoule plast. 100 μg
Description
OverviewRecognizes the ~220 kDa BRCA1 protein in MCF-7 cells. Does not react with blood group antigens or growth factor receptors such as EGFR. Sold under license of U.S. Patent 5,753,441 and 6,162,897.
Catalogue NumberOP93
Brand Family Calbiochem®
SynonymsAnti-Breast Cancer Susceptibility Protein
References
ReferencesScully, R., et al. 1996. Science 272, 123.
Gudas, J.M., et al. 1996. Cell Growth Differ. 7, 717.
Vaughn, J.P., et al. 1996. Cell Growth Differ. 7, 711.
Goldgar, D.E. and Reilly, P.R. 1995. Nat. Genet. 11, 113.
Merajver, S.D., et al. 1995. Clin. Can. Res. 1, 539.
Merajver, S.D., et al. 1995. Nat. Genet. 9, 439.
Struewing, J.P., et al. 1995. Nat. Genet. 11, 198.
Thompson, M.E., et al. 1995. Nat. Genet. 9, 444.
Futreal, P.A., et al. 1994. Science 266, 120.
Miki, Y., et al. 1994. Science 266, 66.
Product Information
DeclarationSold under license of U.S. Patents 5,753,441 and 6,162,897.
FormLiquid
FormulationIn 0.05 M sodium phosphate buffer, 0.2% gelatin.
Positive controlMCF7 cells
Preservative≤0.1% sodium azide
Quality LevelMQ100
Applications
Application ReferencesImmunoblotting, Immunoprecipitation, Immunofluorescence, Paraffin Sections Scully, R., et al. 1996. Science 272, 123.
Key Applications Immunoblotting (Western Blotting)
Immunofluorescence
Immunoprecipitation
Paraffin Sections
Application NotesImmunoblotting (2 µg/ml, chemiluminescence; see application references)
Immunofluorescence (see application references)
Immunoprecipitation (see application references)
Paraffin Sections (see application references)
Application CommentsAntibody should be titrated for optimal results in individual systems.
Biological Information
Immunogenrecombinant, human BRCA1
ImmunogenHuman
Epitopewithin amino acids 1-304
CloneMS13
HostMouse
IsotypeIgG₁
Species Reactivity
  • Human
Antibody TypeMonoclonal Antibody
Concentration Label Please refer to vial label for lot-specific concentration
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Blue Ice Only
Toxicity Standard Handling
Storage +2°C to +8°C
Do not freeze Yes
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Référence GTIN
OP93-100UG 04055977209693

Documentation

Anti-BRCA1 (Ab-2) Mouse mAb (MS13) FDS

Titre

Fiche de données de sécurité des matériaux (FDS) 

Anti-BRCA1 (Ab-2) Mouse mAb (MS13) Certificats d'analyse

TitreNuméro de lot
OP93

Références bibliographiques

Aperçu de la référence bibliographique
Scully, R., et al. 1996. Science 272, 123.
Gudas, J.M., et al. 1996. Cell Growth Differ. 7, 717.
Vaughn, J.P., et al. 1996. Cell Growth Differ. 7, 711.
Goldgar, D.E. and Reilly, P.R. 1995. Nat. Genet. 11, 113.
Merajver, S.D., et al. 1995. Clin. Can. Res. 1, 539.
Merajver, S.D., et al. 1995. Nat. Genet. 9, 439.
Struewing, J.P., et al. 1995. Nat. Genet. 11, 198.
Thompson, M.E., et al. 1995. Nat. Genet. 9, 444.
Futreal, P.A., et al. 1994. Science 266, 120.
Miki, Y., et al. 1994. Science 266, 66.
Fiche technique

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision03-October-2007 RFH
SynonymsAnti-Breast Cancer Susceptibility Protein
ApplicationImmunoblotting (2 µg/ml, chemiluminescence; see application references)
Immunofluorescence (see application references)
Immunoprecipitation (see application references)
Paraffin Sections (see application references)
DescriptionPurified mouse monoclonal antibody generated by immunizing mice with the specified iummunogen and fusing splenocytes with NS1 mouse myeloma cells. Recognizes the ~220 kDa BRCA1 protein.
BackgroundInactivation of the BRCA1 gene, located at 17q21, is responsible for some forms of familial breast and ovarian cancer and sporadic ovarian cancer. BRCA1 encodes a protein of 1863 amino acids with an amino-terminal domain that exhibits similarity to the zinc-ring domain found in several regulatory and transcription factors. Mutations that disrupt this domain are some of the most frequently occurring ones linked to breast and ovarian cancer. Inhibition of BRCA1 expression leads to accelerated growth of mammary cells in vitro while loss of expression is observed during progression from benign disease to metastatic breast cancer suggesting that BRCA1 serves as a negative growth regulator. The ~220 kDa BRCA1 protein is expressed predominantly in the nucleus and appears to undergo cell cycle regulation with mRNA expression induced prior to DNA synthesis.
HostMouse
Immunogen speciesHuman
Immunogenrecombinant, human BRCA1
Epitopewithin amino acids 1-304
CloneMS13
IsotypeIgG₁
Specieshuman
Positive controlMCF7 cells
FormLiquid
FormulationIn 0.05 M sodium phosphate buffer, 0.2% gelatin.
Concentration Label Please refer to vial label for lot-specific concentration
Preservative≤0.1% sodium azide
CommentsAntibody should be titrated for optimal results in individual systems.
Storage +2°C to +8°C
Do Not Freeze Yes
Toxicity Standard Handling
ReferencesScully, R., et al. 1996. Science 272, 123.
Gudas, J.M., et al. 1996. Cell Growth Differ. 7, 717.
Vaughn, J.P., et al. 1996. Cell Growth Differ. 7, 711.
Goldgar, D.E. and Reilly, P.R. 1995. Nat. Genet. 11, 113.
Merajver, S.D., et al. 1995. Clin. Can. Res. 1, 539.
Merajver, S.D., et al. 1995. Nat. Genet. 9, 439.
Struewing, J.P., et al. 1995. Nat. Genet. 11, 198.
Thompson, M.E., et al. 1995. Nat. Genet. 9, 444.
Futreal, P.A., et al. 1994. Science 266, 120.
Miki, Y., et al. 1994. Science 266, 66.
Application referencesImmunoblotting, Immunoprecipitation, Immunofluorescence, Paraffin Sections Scully, R., et al. 1996. Science 272, 123.